Device Trial Radar · NCT05766488
Assessing Continuous Glucose Monitor Use in Underserved Primary Care Patients
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Jul 23, 2023
Primary completion
Jul 20, 2026
Study completion Jul 20, 2026
Sponsor
- Lead sponsor
- University of NebraskaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Great Plains IDeA-CTR
- First posted
- Mar 13, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Continuous glucose monitoring (CGM) has demonstrated improved outcomes in both type 1 and type 2 diabetes populations in comparison to traditional methods; however, these devices have not been well studied in underserved adult patients (e.g., low-income, uninsured) who may face additional barriers to monitoring. Furthermore, there is limited data exploring long-term (3- to 6- month) health care team-based management of these devices in the primary care setting. The purpose of this study is to further understand the benefits and barriers associated with CGM use in underserved populations with type 2 diabetes and improve their overall diabetes care.
Conditions
- Type 2 Diabetes
Interventions
Continuous Glucose Monitor (CGM)Device
A Freestyle Libre 2 continuous glucose monitor (CGM) will be provided in the experimental arm of this study for 6 months.
Self-monitoring Blood Glucose (SMBG)Device
A traditional glucometer device will be assigned in the active comparitor arm of this study for 6 months.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Glycemic Control (Hemoglobin A1c)Time frame: Baseline, 3 months, and 6 months.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Nebraska Medicine
Omaha, Nebraska
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.